Secondly, metformin can directly activate adenosine monophosphatase-activated protein kinase pathway by reducing insulin-like growth factor levels, inhibit insulin signaling, thereby reducing tumor glucose supply and playing a role in inhibiting tumor growth33. This evidence concerns the gene INS and neoplasm.